GB2476907A - System of authorization and method - Google Patents

System of authorization and method Download PDF

Info

Publication number
GB2476907A
GB2476907A GB1107004A GB201107004A GB2476907A GB 2476907 A GB2476907 A GB 2476907A GB 1107004 A GB1107004 A GB 1107004A GB 201107004 A GB201107004 A GB 201107004A GB 2476907 A GB2476907 A GB 2476907A
Authority
GB
United Kingdom
Prior art keywords
applicant
doctor
responses
group
prescription
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB1107004A
Other versions
GB201107004D0 (en
Inventor
Jonathan Tribe
Ken Dawson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INFLUENZA PROT Ltd
MEDICAL PRESCRIPTION SERVICES Ltd
Original Assignee
INFLUENZA PROT Ltd
MEDICAL PRESCRIPTION SERVICES Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INFLUENZA PROT Ltd, MEDICAL PRESCRIPTION SERVICES Ltd filed Critical INFLUENZA PROT Ltd
Publication of GB201107004D0 publication Critical patent/GB201107004D0/en
Publication of GB2476907A publication Critical patent/GB2476907A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G06—COMPUTING; CALCULATING OR COUNTING
    • G06Q—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL OR SUPERVISORY PURPOSES, NOT OTHERWISE PROVIDED FOR
    • G06Q10/00—Administration; Management
    • G06Q10/10—Office automation; Time management
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients

Landscapes

  • Engineering & Computer Science (AREA)
  • Business, Economics & Management (AREA)
  • Health & Medical Sciences (AREA)
  • Strategic Management (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Public Health (AREA)
  • Entrepreneurship & Innovation (AREA)
  • Human Resources & Organizations (AREA)
  • Economics (AREA)
  • General Business, Economics & Management (AREA)
  • Marketing (AREA)
  • Operations Research (AREA)
  • Quality & Reliability (AREA)
  • Tourism & Hospitality (AREA)
  • Physics & Mathematics (AREA)
  • Data Mining & Analysis (AREA)
  • General Physics & Mathematics (AREA)
  • Theoretical Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Treatment And Welfare Office Work (AREA)

Abstract

Pre-stored, on-line and tailored questionnaires (130) are provided in a secure fashion to an applicant (14), such as a patient, in advance of that applicant receiving advice or treatment. Based on theapplicant's responses (138, 176, 194) and a correlation (140, 5 170) against stored data for a particular drug or form of treatment, the applicant (14) is automatically categorized into one of three groups requiring varying degrees of contact or supplemental assessment. In a first group, the applicant's responses are deemed sufficiently robust to permit the direct approval (144, 146) of a prescription through an electronic authorization by a doctor. In a second group, a qualified approval (172) is 10 authorised( 180, 182) by the doctor based on supplementary information (176) and consideration. A third group requires a doctor's direct intervention and consideration (198). The system is arranged to identify responses from the applicant (14) that deviate from all acceptable pre-stored range of responses to a particular question or group of questions in the questionnaire, thereby allowing the different categories to be processed 15 at different rates. With the provision of electronic approvals, an affiliated pharmacist having access to the system permits the pharmacist to have confidence in the validity of the prescription and authorising doctor, such that the prescription can be dispensed directly and in a timely fash-ion to the applicant through courier or standard postal channels.
GB1107004A 2008-10-06 2009-10-06 System of authorization and method Withdrawn GB2476907A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0818247.9A GB0818247D0 (en) 2008-10-06 2008-10-06 System of authorization and method
PCT/GB2009/051317 WO2010041052A1 (en) 2008-10-06 2009-10-06 System of authorization and method

Publications (2)

Publication Number Publication Date
GB201107004D0 GB201107004D0 (en) 2011-06-08
GB2476907A true GB2476907A (en) 2011-07-13

Family

ID=40042327

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0818247.9A Ceased GB0818247D0 (en) 2008-10-06 2008-10-06 System of authorization and method
GB1107004A Withdrawn GB2476907A (en) 2008-10-06 2009-10-06 System of authorization and method

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GBGB0818247.9A Ceased GB0818247D0 (en) 2008-10-06 2008-10-06 System of authorization and method

Country Status (2)

Country Link
GB (2) GB0818247D0 (en)
WO (1) WO2010041052A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10910091B2 (en) 2016-12-20 2021-02-02 Astrazeneca Uk Ltd. Systems and methods for dispensing a statin medication over the counter
US10600502B2 (en) 2016-12-20 2020-03-24 Astrazeneca Uk Ltd. Systems and methods for dispensing a statin medication over the counter
CN117542473A (en) 2018-06-14 2024-02-09 阿斯利康(英国)有限公司 Method for treating hypertension with pharmaceutical compositions of angiotensin II receptor blockers
JP7470646B2 (en) 2018-06-14 2024-04-18 アストラゼネカ・ユーケイ・リミテッド Methods for treating and preventing asthma symptoms with corticosteroid pharmaceutical compositions - Patents.com
CN112955967A (en) 2018-06-14 2021-06-11 阿斯利康(英国)有限公司 Method for treating erectile dysfunction using pharmaceutical compositions of CGMP-specific phosphodiesterase 5 inhibitors
CN112955965B (en) 2018-06-14 2024-04-09 阿斯利康(英国)有限公司 Method for lowering blood pressure using dihydropyridine calcium channel blocker pharmaceutical compositions
CA3103617A1 (en) * 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for lowering blood sugar with a metformin pharmaceutical composition
WO2019241568A1 (en) 2018-06-14 2019-12-19 Astrazeneca Uk Limited Methods for lowering blood sugar with a gliflozin sodium-glucose cotransporter 2 inhibitor pharmaceutical composition
JP7372943B2 (en) * 2018-06-14 2023-11-01 アストラゼネカ・ユーケイ・リミテッド Method for lowering blood sugar using dipeptidyl peptidase-4 inhibitor pharmaceutical compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052760A1 (en) * 2000-03-27 2002-05-02 Munoz Michael A. System and method for automated prescription management
US20030154106A1 (en) * 2002-01-25 2003-08-14 Body Health Resources Corporation System and method for renewing prescriptions

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020052760A1 (en) * 2000-03-27 2002-05-02 Munoz Michael A. System and method for automated prescription management
US20030154106A1 (en) * 2002-01-25 2003-08-14 Body Health Resources Corporation System and method for renewing prescriptions

Also Published As

Publication number Publication date
GB201107004D0 (en) 2011-06-08
WO2010041052A1 (en) 2010-04-15
GB0818247D0 (en) 2008-11-12

Similar Documents

Publication Publication Date Title
GB2476907A (en) System of authorization and method
Ross et al. Prescribing and the core curriculum for tomorrow's doctors: BPS curriculum in clinical pharmacology and prescribing for medical students
DeLegge et al. State of nutrition support teams
Joo et al. An exploratory study of health scientists’ data reuse behaviors: Examining attitudinal, social, and resource factors
Maxwell et al. Educating European (junior) doctors for safe prescribing
Angelo et al. Impact of community pharmacy automation on workflow, workload, and patient interaction
Dcruz et al. The rise of E-pharmacy in India: Benefits, challenges, and the road ahead
Hertig et al. Evaluation of pharmacists’ awareness of illegal online pharmacies and perceived impact on safe access to medicines
Hohenschurz-Schmidt et al. Research objectives and general considerations for pragmatic clinical trials of pain treatments: IMMPACT statement
Herawati et al. Educational video improves knowledge about outpatients’ usage of antibiotics in two public hospitals in Indonesia
Imwinkelried Impoverishing the Trier of Fact: Excluding the Proponent Expert Testimony Due to the Opponent's Inability to Afford Rebuttal Evidence
Gopalan Ethical and regulatory gaps in aesthetic medical practice in top Asian medical tourism destinations
Rangnekar Context and Ambiguity in the Making of Law: A Comment on Amending India's Patent Act
Centanni et al. Biotechnology operations: principles and practices
Lorenc et al. The education process for pharmacists in Poland: standards and proposed changes
Foe Owono Impact of EU medical device directive on medical device software
Wieringa et al. Connecting pre-marketing clinical research and medical practice: opinion-based study of core issues and possible changes in drug regulation
Jones et al. Real-World Data and Randomised Controlled Trials: The Salford Lung Study
Lestari et al. Systematic Literature Review on The Use of Electronic Prescribing (E-Prescribing) At Hospital Installation
Herrier Patient counseling in pharmacy: through the looking glass
Toshev et al. Digitalization of health care and aspects of implementing electronic prescriptions in Bulgaria
Peacock et al. Patient care services in independent community pharmacies: a descriptive report
Durkin Ostroff Stresses Importance Of ‘Cures’ Hiring Language
Blumer Beinor v. Industrial Claims Appeals Office
Brown Reducing Outpatient Antibiotic Resistance: A Quasi-Experimental Study

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)